After completing the injection, hold the needle in place for 5-10 seconds before withdrawing
Our study also indicated that GSMT3 could inhibit PDAC cell proliferation and glycolysis
Stimulates the use of free fatty acids for energy production

Immediate consultation is warranted for: Severe or persistent nausea and vomiting lasting more than 48 hours or preventing any oral intake, as this may indicate gastroparesis or require medication adjustment Severe, persistent abdominal pain , which could indicate pancreatitis (a rare but serious adverse effect of GLP-1 medications) Right upper quadrant pain, fever, or yellowing of skin/eyes , which may suggest gallbladder disease (more common during rapid weight loss) Unintentional protein intake below 0.8 grams per kilogram of body weight for more than one week, suggesting inadequate nutritional support Signs of muscle wasting including significant weakness, difficulty with previously manageable physical activities, or visible muscle loss Symptoms of dehydration such as dark urine, dizziness, or decreased urination, particularly when combined with poor protein intake Hair loss, brittle nails, or skin changes that may indicate protein-calorie malnutrition Unexpectedly rapid weight loss exceeding 23 pounds per week consistently, which increases risk of lean mass depletion Routine nutritional assessment should occur at regular intervals during semaglutide treatment

Dietary adjustments include: Eating smaller, more frequent meals rather than large portions, which can overwhelm the already slowed digestive system Reducing intake of gas-producing foods such as beans, lentils, cruciferous vegetables (broccoli, cauliflower, cabbage), onions, and carbonated beverages Limiting high-fat foods , as these delay gastric emptying further and may worsen bloating Avoiding artificial sweeteners (sorbitol, mannitol, xylitol) found in sugar-free products, which can ferment in the gut Chewing food thoroughly and eating slowly to reduce air swallowing (aerophagia) Staying well hydrated , particularly if constipation is contributing to gas and bloating Lifestyle measures can also be beneficial
Knockdown of FSTL1 inhibits microglia activation and alleviates depressive-like symptoms through modulating TLR4/MyD88/NF-B pathway in CUMS mice